{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:46:56Z","timestamp":1792136816878,"version":"4.4.0"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>\n                    Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) is a rare and aggressive T-cell lymphoma with incompletely characterized features. We analyzed 120 Chinese patients (88 males, 32 females; median age 58y), including 43% at stage I. All patients had gastrointestinal (GI) involvement, with 78% confined to the small intestine. The tumor cells were typically monomorphic and medium-sized, expressing CD3 (99%), CD7 (90%), CD8 (94%), CD56 (90%), and TIA-1 (97%). Low expression rates were noted for CD4 (9%) and CD5 (13%). CD20 was aberrantly expressed in 4% cases. TCR\u03b1\u03b2 expression was more common than TCR\u03b3\u03b4 (1.1:1). The next-generation sequencing (NGS) results showed that all cases had loss-of-function mutations in\n                    <jats:italic toggle=\"yes\">SETD2<\/jats:italic>\n                    (100%). Other frequently mutated genes included\n                    <jats:italic toggle=\"yes\">STAT5B<\/jats:italic>\n                    (67%),\n                    <jats:italic toggle=\"yes\">JAK3<\/jats:italic>\n                    (50%),\n                    <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                    (33%), and\n                    <jats:italic toggle=\"yes\">KRAS<\/jats:italic>\n                    (22%). All patients had detectable single nucleotide polymorphisms (SNPs). Copy number variations (CNVs) were detected in\n                    <jats:italic toggle=\"yes\">TSC2<\/jats:italic>\n                    (11%),\n                    <jats:italic toggle=\"yes\">CDH1<\/jats:italic>\n                    (5%),\n                    <jats:italic toggle=\"yes\">STK11<\/jats:italic>\n                    (5%),\n                    <jats:italic toggle=\"yes\">CDKN2B<\/jats:italic>\n                    (5%), and\n                    <jats:italic toggle=\"yes\">SDHD<\/jats:italic>\n                    (5%). In addition, novel fusions involving\n                    <jats:italic toggle=\"yes\">PML<\/jats:italic>\n                    -\n                    <jats:italic toggle=\"yes\">RPH3A<\/jats:italic>\n                    (5%),\n                    <jats:italic toggle=\"yes\">TP63<\/jats:italic>\n                    -\n                    <jats:italic toggle=\"yes\">PRKAR2A<\/jats:italic>\n                    (5%),\n                    <jats:italic toggle=\"yes\">MAD2L1<\/jats:italic>\n                    -\n                    <jats:italic toggle=\"yes\">CD28<\/jats:italic>\n                    (5%), and\n                    <jats:italic toggle=\"yes\">DPP6<\/jats:italic>\n                    -\n                    <jats:italic toggle=\"yes\">TP63<\/jats:italic>\n                    (5%), were identified. Among these patients, 89% underwent surgery, 83% received systemic chemotherapy, and 7% received stem cell transplantation (SCT). The median overall survival (OS) of 77 patients was 9 months. Age 58 years or older and Ki-67 &gt;50% were significantly associated with poor prognosis in univariate analysis, while Ki-67 &gt;50% and the presence of B symptoms were independent adverse prognostic factors in multivariate analysis. Our findings expand the molecular spectrum of MEITL and support precision medicine approaches for this therapy-resistant disease.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002629","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:00:19Z","timestamp":1792134019000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma"],"prefix":"10.1097","author":[{"given":"Keya","family":"Li","sequence":"first","affiliation":[{"name":"Department of Pathology, Fudan University Shanghai Cancer Center"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University"},{"name":"Department of Pathology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fudan University Shanghai Cancer Center"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhen","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fudan University Shanghai Cancer Center"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruohong","family":"Shui","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fudan University Shanghai Cancer Center"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfen","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fudan University Shanghai Cancer Center"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fudan University Shanghai Cancer Center"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongzeng","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fudan University Shanghai Cancer Center"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fudan University Shanghai Cancer Center"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohua","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fudan University Shanghai Cancer Center"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"R1-20261016","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0002-9440(10)65736-7","article-title":"Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology","volume":"153","author":"Chott","year":"1998","journal-title":"Am J Pathol"},{"key":"R2-20261016","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1182\/blood.2023021788","article-title":"Current and upcoming treatment approaches to uncommon subtypes of PTCL (EATL, MEITL, SPTCL, and HSTCL)","volume":"144","author":"Marchi","year":"2024","journal-title":"Blood"},{"key":"R3-20261016","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/modpathol.2015.85","article-title":"Genomic and immunohistochemical profiles of enteropathy-associated T-cell lymphoma in Japan","volume":"28","author":"Tomita","year":"2015","journal-title":"Mod Pathol"},{"key":"R4-20261016","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1084\/jem.20160894","article-title":"Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2","volume":"214","author":"Moffitt","year":"2017","journal-title":"J Exp Med"},{"key":"R5-20261016","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.humpath.2009.11.020","article-title":"Enteropathy-associated T-cell lymphoma\u2013a clinicopathologic and array comparative genomic hybridization study","volume":"41","author":"Ko","year":"2010","journal-title":"Hum Pathol"},{"key":"R6-20261016","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2011-02-335216","article-title":"Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project","volume":"118","author":"Delabie","year":"2011","journal-title":"Blood"},{"key":"R7-20261016","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.3390\/cancers15102743","article-title":"Clinical and Histopathological Features of an Italian Monocentric Series of Primary Small Bowel T-Cell Lymphomas","volume":"15","author":"Lucioni","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R8-20261016","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3324\/haematol.2022.281226","article-title":"Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome","volume":"108","author":"Veloza","year":"2023","journal-title":"Haematologica"},{"key":"R9-20261016","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.4251\/wjgo.v14.i11.2273","article-title":"Surgical management of monomorphic epitheliotropic intestinal T-cell lymphoma followed by chemotherapy and stem-cell transplant: a case report and review of the literature","volume":"14","author":"Bissessur","year":"2022","journal-title":"World J Gastrointest Oncol"},{"key":"R10-20261016","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/modpathol.2017.145","article-title":"SYK expression in monomorphic epitheliotropic intestinal T-cell lymphoma","volume":"31","author":"Mutzbauer","year":"2018","journal-title":"Mod Pathol"},{"key":"R11-20261016","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/leu.2013.41","article-title":"Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8\u03b1\u03b1 phenotype","volume":"27","author":"Tan","year":"2013","journal-title":"Leukemia"},{"key":"R12-20261016","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13000-021-01173-5","article-title":"Clinicopathological and molecular genomic features of monomorphic epitheliotropic intestinal T-cell lymphoma in the Chinese population: a study of 20 cases","volume":"16","author":"Chen","year":"2021","journal-title":"Diagn Pathol"},{"key":"R13-20261016","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/PAS.0000000000001914","article-title":"Targeted next-generation sequencing reveals a wide morphologic and immunophenotypic spectrum of monomorphic epitheliotropic intestinal T-cell lymphoma","volume":"46","author":"Hang","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R14-20261016","doi-asserted-by":"crossref","first-page":"12602","DOI":"10.1038\/ncomms12602","article-title":"Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations","volume":"7","author":"Roberti","year":"2016","journal-title":"Nat Commun"},{"key":"R15-20261016","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/leu.2016.13","article-title":"JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma","volume":"30","author":"Nairism\u00e4gi","year":"2016","journal-title":"Leukemia"},{"key":"R17-20261016","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/PAS.0000000000002258","article-title":"Characteristics and clinical value of MYC, BCL2, and BCL6 rearrangement detected by next-generation sequencing in DLBCL","volume":"48","author":"Zeng","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"R18-20261016","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat Protoc"},{"key":"R19-20261016","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/ng.3400","article-title":"The genomic landscape of juvenile myelomonocytic leukemia","volume":"47","author":"Stieglitz","year":"2015","journal-title":"Nat Genet"},{"key":"R20-20261016","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/s41467-018-04013-1","article-title":"The molecular basis of JAK\/STAT inhibition by SOCS1","volume":"9","author":"Liau","year":"2018","journal-title":"Nat Commun"},{"issue":"suppl 1","key":"R21-20261016","first-page":"S68","article-title":"Classification of intestinal T-cell neoplasms and their differential diagnosis","volume":"111","author":"Chott","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"R22-20261016","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.humpath.2013.10.038","article-title":"Detailed clinicopathological characteristics and possible lymphomagenesis of type II intestinal enteropathy-associated T-cell lymphoma in Japan","volume":"45","author":"Kikuma","year":"2014","journal-title":"Hum Pathol"},{"key":"R23-20261016","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2559.2011.03768.x","article-title":"Pathological and immunohistological findings and genetic aberrations of intestinal enteropathy-associated T cell lymphoma in Japan","volume":"58","author":"Takeshita","year":"2011","journal-title":"Histopathology"},{"key":"R24-20261016","doi-asserted-by":"crossref","first-page":"2058738419829387","DOI":"10.1177\/2058738419829387","article-title":"Monomorphic epitheliotropic intestinal T-cell lymphoma may mimic intestinal inflammatory disorders","volume":"33","author":"Tian","year":"2019","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R25-20261016","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12185-021-03107-9","article-title":"Early central nervous system relapse of monomorphic epitheliotropic intestinal T-cell lymphoma after cord blood transplantation","volume":"114","author":"Nato","year":"2021","journal-title":"Int J Hematol"},{"key":"R26-20261016","doi-asserted-by":"crossref","first-page":"e31326","DOI":"10.1097\/MD.0000000000031326","article-title":"Pegylated liposomal doxorubicin (PLD)-containing regimen as a novel treatment of monomorphic epithelial intestinal T-cell lymphoma (MEITL): a case report and review of literature","volume":"101","author":"Chen","year":"2022","journal-title":"Medicine"},{"key":"R27-20261016","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"R28-20261016","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.3390\/cancers13225774","article-title":"Primary gastrointestinal T-cell lymphoma and indolent lymphoproliferative disorders: practical diagnostic and treatment approaches","volume":"13","author":"Nishimura","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R29-20261016","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/PAS.0b013e318222dfcd","article-title":"Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent \u03b3\u03b4 T-cell receptor expression","volume":"35","author":"Chan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R30-20261016","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1182\/bloodadvances.2020001782","article-title":"Whole-genome sequencing reveals potent therapeutic strategy for monomorphic epitheliotropic intestinal T-cell lymphoma","volume":"4","author":"Huang","year":"2020","journal-title":"Blood Adv"},{"key":"R31-20261016","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s40001-024-01797-5","article-title":"Clinicopathological and molecular genetic alterations in monomorphic-epitheliotropic intestinal T-cell lymphoma of the small intestine","volume":"29","author":"Zhou","year":"2024","journal-title":"Eur J Med Res"},{"key":"R32-20261016","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/ijlh.14398","article-title":"Relapse of monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) in a pericardial fluid","volume":"47","author":"Bera","year":"2025","journal-title":"Int J Lab Hematol"},{"key":"R33-20261016","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/1066896920953906","article-title":"Monomorphic epitheliotropic intestinal t-cell lymphoma of the stomach: two case reports and a literature review","volume":"29","author":"Lu","year":"2021","journal-title":"Int J Surg Pathol"},{"key":"R34-20261016","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1038\/leu.2016.178","article-title":"Mutations in the JAK\/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas","volume":"30","author":"Nicolae","year":"2016","journal-title":"Leukemia"},{"key":"R35-20261016","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/ncomms7025","article-title":"Activating mutations of STAT5B and STAT3 in lymphomas derived from \u03b3\u03b4-T or NK cells","volume":"6","author":"K\u00fc\u00e7\u00fck","year":"2015","journal-title":"Nat Commun"},{"key":"R36-20261016","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.3390\/cancers12123539","article-title":"Monomorphic epitheliotropic intestinal T-cell lymphoma in Asia frequently shows SETD2 alterations","volume":"12","author":"Tomita","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R37-20261016","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00018-003-3027-6","article-title":"Redefining tumour suppressor genes: exceptions to the two-hit hypothesis","volume":"60","author":"Paige","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"R38-20261016","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13059-025-03483-z","article-title":"SETD2 loss-of-function uniquely sensitizes cells to epigenetic targeting of NSD1-directed H3K36 methylation","volume":"26","author":"Wagner","year":"2025","journal-title":"Genome Biol"},{"key":"R39-20261016","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ccell.2015.09.015","article-title":"Inhibiting WEE1 selectively kills histone H3K36me3-deficient cancers by dNTP starvation","volume":"28","author":"Pfister","year":"2015","journal-title":"Cancer Cell"},{"key":"R40-20261016","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00018-022-04361-8","article-title":"In vivo impact of JAK3 A573V mutation revealed using zebrafish","volume":"79","author":"Basheer","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"R41-20261016","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/2159-8290.CD-16-0330","article-title":"The genetic basis of hepatosplenic T-cell lymphoma","volume":"7","author":"McKinney","year":"2017","journal-title":"Cancer Discov"},{"key":"R42-20261016","doi-asserted-by":"crossref","first-page":"e010783","DOI":"10.1136\/jitc-2024-010783","article-title":"JAK3 (A573V) and JAK3 (M511I) mutations in peripheral T-cell lymphoma mediating resistance to anti-PD-1 therapy through the STAT3\/PD-L1 pathway","volume":"13","author":"Lou","year":"2025","journal-title":"J Immunother Cancer"},{"key":"R43-20261016","first-page":"101550","article-title":"Extranodal NK\/T-cell lymphoma: an update of the molecular characterization of the tumor and microenvironment, and its clinical implications","volume":"62","author":"Chan","year":"2025","journal-title":"Lancet Reg Health West Pac"},{"key":"R44-20261016","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41375-025-02777-2","article-title":"Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma","volume":"40","author":"Vallois","year":"2026","journal-title":"Leukemia"},{"key":"R45-20261016","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/biom15010064","article-title":"SNP rs9364554 modulates androgen receptor binding and drug response in prostate cancer","volume":"15","author":"Yan","year":"2025","journal-title":"Biomolecules"},{"key":"R46-20261016","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrd840","article-title":"Genome-based pharmacogenetics and the pharmaceutical industry","volume":"1","author":"Roses","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"R47-20261016","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00228-016-2015-3","article-title":"Improvement of a predictive model in ovarian cancer patients submitted to platinum-based chemotherapy: implications of a GST activity profile","volume":"72","author":"Pereira","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"key":"R48-20261016","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40364-020-00213-4","article-title":"Application of pharmacogenetics in oncology","volume":"8","author":"Miteva-Marcheva","year":"2020","journal-title":"Biomark Res"},{"key":"R49-20261016","doi-asserted-by":"crossref","first-page":"300060519879588","DOI":"10.1177\/0300060519879588","article-title":"Association of MTHFR and RFC1 gene polymorphisms with methotrexate efficacy and toxicity in Chinese Han patients with rheumatoid arthritis","volume":"48","author":"Wang","year":"2020","journal-title":"J Int Med Res"},{"key":"R50-20261016","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41408-020-0310-9","article-title":"DNA methylation and copy number variation profiling of T-cell lymphoblastic leukemia and lymphoma","volume":"10","author":"Haider","year":"2020","journal-title":"Blood Cancer J"},{"key":"R51-20261016","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1182\/blood-2012-02-414441","article-title":"TBL1XR1\/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma","volume":"119","author":"Scott","year":"2012","journal-title":"Blood"},{"key":"R52-20261016","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/his.14005","article-title":"Fluorescence in-situ hybridisation for TP63 rearrangements in T cell lymphomas: single-site experience of 470 patients and implications for clinical testing","volume":"76","author":"Peterson","year":"2020","journal-title":"Histopathology"},{"key":"R53-20261016","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/PAS.0000000000001941","article-title":"Immunohistochemical approach to genetic subtyping of anaplastic large cell lymphoma","volume":"46","author":"Feldman","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R54-20261016","doi-asserted-by":"crossref","first-page":"eadi7244","DOI":"10.1126\/scitranslmed.adi7244","article-title":"TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence","volume":"15","author":"Wu","year":"2023","journal-title":"Sci Transl Med"},{"key":"R55-20261016","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/his.14674","article-title":"RNAseq identification of FISH-cryptic BCL6::TP63 rearrangement in ALK-negative anaplastic large-cell lymphoma","volume":"81","author":"Ahmed","year":"2022","journal-title":"Histopathology"},{"key":"R56-20261016","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13072-024-00529-7","article-title":"TP63-TRIM29 axis regulates enhancer methylation and chromosomal instability in prostate cancer","volume":"17","author":"Sultanov","year":"2024","journal-title":"Epigenetics Chromatin"},{"key":"R57-20261016","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.3390\/biomedicines10082038","article-title":"Genomic aberrations generate fusion gene FOXK2::TP63 and activate NFKB1 in cutaneous T-cell lymphoma","volume":"10","author":"Nagel","year":"2022","journal-title":"Biomedicines"},{"key":"R58-20261016","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ajh.23213","article-title":"Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group","volume":"87","author":"Tse","year":"2012","journal-title":"Am J Hematol"},{"key":"R59-20261016","doi-asserted-by":"crossref","first-page":"1388623","DOI":"10.3389\/fonc.2024.1388623","article-title":"Hematopoietic stem cell transplantation to improve prognosis in aggressive monomorphic epitheliotropic intestinal T-cell lymphoma","volume":"14","author":"Min","year":"2024","journal-title":"Front Oncol"},{"key":"R60-20261016","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1007\/s00277-019-03791-y","article-title":"Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma","volume":"98","author":"Yi","year":"2019","journal-title":"Ann Hematol"},{"key":"R61-20261016","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3332\/ecancer.2017.771","article-title":"Use of PEG-asparaginase in monomorphic epitheliotropic intestinal T-cell lymphoma, a disease with diagnostic and therapeutic challenges","volume":"11","author":"Gentille","year":"2017","journal-title":"Ecancermedicalscience"},{"key":"R62-20261016","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2012-05-431460","article-title":"SMILE for natural killer\/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group","volume":"120","author":"Kwong","year":"2012","journal-title":"Blood"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002629","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:00:26Z","timestamp":1792134026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002629"}},"subtitle":["Clinicopathologic and Genetic Analysis of a Large Chinese Cohort"],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":61,"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002629","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]}}}